Lv4
610 积分 2022-01-11 加入
Discovery of CZL-149: A Novel, Highly Potent, and Orally Bioavailable Dual Inhibitor Targeting BET and p300/CBP Bromodomains with Strong Antitumor Efficacy
2个月前
已完结
From G12C To Pan-RAS: The Expanding Therapeutic Landscape of KRAS-Mutant NSCLC
3个月前
已完结
Mutational and Kinetic Analyses of the GTPase-Activating Protein (GAP)-p21 Interaction: The C-Terminal Domain of GAP Is Not Sufficient for Full Activity
3个月前
已关闭
Mutational and Kinetic Analyses of the GTPase-Activating Protein (GAP)-p21 Interaction: The C-Terminal Domain of GAP Is Not Sufficient for Full Activity
3个月前
已关闭
Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies
4个月前
已完结
From KRAS G12D to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug Design
4个月前
已完结
Quantitative analysis of ternary complex kinetics by a surface immobilization method
4个月前
已关闭
Multiparameter Analysis of a Screen for Progesterone Receptor Ligands: Comparing Fluorescence Lifetime and Fluorescence Polarization Measurements
4个月前
已完结
Structural Insights into Interaction Mechanisms of Alternative Piperazine-urea YEATS Domain Binders in MLLT1
5个月前
已完结
Design and Development of DNA Damage Chemical Inducers of Proximity for Targeted Cancer Therapy
5个月前
已完结
皖公网安备34019202002308
